Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Motion Sickness: early-phase trial registry

3 of 7 indexed Motion Sickness trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Motion Sickness: 7 US clinical trials tracked, 3 recruiting.

Motion Sickness is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is 59th Medical Wing, running 1 of these trials.

Enrollment posture brief

Registry condition motion-sickness

OPEN 3 | RECR 43% | LATE 1 | EARLY 2 | RANK #2497 | SPON 1

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Motion Sickness (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Motion Sickness

Motion Sickness lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Motion Sickness on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Motion Sickness is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Motion Sickness trials is spread across many organizations.

    59th Medical Wing accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Most Motion Sickness trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 7 trials that report a genuine target (sentinel values excluded). 6 of those (85.7%) plan for fewer than 100 participants.

  4. Motion Sickness research is mostly interventional.

    6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 31

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 1

Named interventions

Most-linked intervention names on Motion Sickness records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Tradipitant Drug
1 trials
3-DOF Bertec Portable Essential's dual-balance force plate system Other
1 trials
Flight simulations in virtual reality (VR) Other
1 trials
Galvanic Vestibular Stimulation (GVS) Device
1 trials
Scopolamine Drug
1 trials
Transcutaneous Auricular Neurostimulation device Device
1 trials
Placebo Nasal Gel Drug
1 trials
DPI-386 Nasal Gel Drug
1 trials

US sites by state

Facility locations filed on Motion Sickness trials. A trial with sites in several states counts in each.

Texas 2 trials
California 2 trials
Ohio 1 trials
New Hampshire 1 trials
Maryland 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Motion Sickness page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Motion Sickness condition card totals 7 registered trials; most-linked intervention Tradipitant; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.